Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

BeiGene Reports Positive Data, And Other News: The Good, Bad, And Ugly Of Biopharma [Seeking Alpha]

BeiGene, Ltd. - American Depositary Shares (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
Company Research Source: Seeking Alpha
SummaryA phase 3 trial at BeiGene met its primary endpoint.Molina calls off deal.Alnylam gets its drug fast-tracked.BeiGene Reports Phase 3 Trial Meeting Primary EndpointBeiGene Ltd. (NASDAQ:BGNEreportedBeiGene is now looking to file a supplemental new drug application for the drug candidate as a first-line treatment for non-squamous NSCLC with the drug authorities in China. Yong (Ben) Ben, M.D., Chief Medical Officer, Immuno-Oncology at BeiGene said,"These results add to our growing body of evidence demonstrating the efficacy and safety of tislelizumab for the treatment of advanced cancers. We look forward to continuing to evaluate tislelizumab in more than 25 studies, including 15 potentially registration-enabling trials."Tislelizumab is an anti-PD-1 antibody designed for treating non-squamous non-small cell lung cancer.BGB-A317-304 is a Phase 3, open-label, multi-center, randomized trial. It aims to assess tislelizumab at 200mg dosage every three weeks in conjunction with pemetrexe Show less Read more
Impact Snapshot
Event Time:
BGNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BGNE alerts
Opt-in for
BGNE alerts

from News Quantified
Opt-in for
BGNE alerts

from News Quantified